Prosiectau (2914)
Cardiff University Schools involved in this Project
The PELICAN project - Pupil perceptions of clinical trials, health research and public and patient involvement (02.01.2019 - 31.03.2020)
- Smallman, Kim
-
- van den Bree, Marianne
The regulation of protective immunity to viruses by L-selection (09.01.2019 - 11.08.2023)
- Ager, Ann
TG1101-RMS302 Phase III: UbLiTuximab in Multiple Sclerosis treatment effects (ULTIMATE II STUDY) (11.01.2019 - 31.01.2021)
- Robertson, Neil
Genetic investigation of the relationship between sleep and bipolar disorder (15.01.2019 - 15.03.2022)
- Di Florio, Arianna
Treatment of hidradenitis suppurativa evaluation study (THESEUS) (22.01.2019 - 30.09.2024)
- Ingram, John
A comprehensive assessment of motor and non-motor symptoms in primary blepharospasm to aid stratification of disorder phenotypes (28.01.2019 - 31.05.2021)
- Peall, Kathryn
The UK-Japan genetics and genomic research network (31.01.2019 - 31.07.2022)
- Doheny, Shane
Barriers to accessing hyperacute stroke and thrombectomy services in stroke survivors and the public from deprived communities (01.02.2019 - 01.10.2021)
- Hewitt, Jonathan
Deducing and ordering the earliest cellular response to native alpha-synuclein exposure (01.02.2019 - 31.01.2020)
- Webber, Caleb
Exploring the feasibility of an internet-based cognitive behavioural therapy programme as a non-pharmaceutical therapeutic intervention for people diagnosed with primary dystonia (01.02.2019 - 31.12.2021)
- Peall, Kathryn
Help me quit smoking cessation decision aid (01.02.2019 - 31.07.2019)
High-throughput identification of common CD8+T cell responses to SIV and M. tuberculosis in rhesus macaques (01.02.2019 - 31.01.2024)
- Price, David
MORE PRECISE - Morbidity Prevalence Estimate In StrokE: A 'multi-stie' cohort study from index event to 6 months Post-Stroke (01.02.2019 - 07.03.2019)
- Carson-Stevens, Andrew
PAtient-centred Care for FIbromyalgia: New pathway Design (PACFIND) (01.02.2019 - 30.09.2025)
- Choy, Ernest
Using patient derived gastric cancer organoids to identify which patients will respond to different chemotherapeutic regimens based on molecular subtype (01.02.2019 - 31.08.2020)
- Powell, Arfon
Validation of the Mycoplasma IST3 performance (04.02.2019 - 31.07.2019)
- Spiller, Brad
Determining the clinical and environmental impact, burden and cost of extensively drug resistant enterobacteriaceae in china (DETER-XDRE-CHINA-HUB) (14.02.2019 - 13.02.2022)
- Walsh, Timothy
Developing novel CRISP-Cas9 variants for efficient in vivo contraction of CTG/CAG repeats (15.02.2019 - 15.05.2021)
- Dion, Vincent
Observational chart review of patients with Rheumatoid Arthritis treated with Abatacept (28.02.2019 - 31.12.2019)
- Choy, Ernest
A multicentre cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of a school based peer-led drug prevention intervention (The FRANK friends study) (01.03.2019 - 31.03.2024)
- White, James
A multi-site, prospective, longitudinal, cohort study measuring cerebrospinal fluid-mutant Huntington protein in patients with Huntington's disease (01.03.2019 - 28.02.2021)
- Busse-Morris, Monica
Development of Australian PTSD Guidelines (01.03.2019 - 31.12.2024)
- Bisson, Jonathan
Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis (01.03.2019 - 28.02.2023)
- O'Donnell, Valerie
Immune fingerprinting of low grade hepatic encephalopathy (01.03.2019 - 31.12.2022)
- Pembroke, Thomas
MRC Centre for Neuropsychiatric Genetics and Genomics (01.03.2019 - 31.03.2020)
- Owen, Michael
-
- Clarke, Angus
Patients first inflammation ASPIRE 2018 rheumatology - Effect of tofacitinib on central pain processing in rheumatoid arthritis (01.03.2019 - 31.03.2024)
- Choy, Ernest
SNSF professorships (01.03.2019 - 30.09.2019)
- Dion, Vincent
-
- Knapper, Steven
Investigating the role of patient bone marrow stroma in relapsing AML post allogeneic stem cell transplantation - A study to pre-empt early relapse (05.03.2019 - 28.02.2024)
- Alvares, Caroline
IMCY-T1D-002: Long term follow-up study of T1D patients previously treated with IMCY-0098 or placebo (19.03.2019 - 31.03.2020)
- Dayan, Colin
Pulmonary epithelial barrier and immunological functions at birth and in early life, key determinants of the development of asthma (19.03.2019 - 19.09.2022)
- Ghazal, Peter
A two-part, randomized, open-label, multicentre, phase 2a/2b study of the efficacy, safety, and pharmacokinetics of KRT-232 compared to Ruxolitinib in patients with phlebotomy-dependent Polycythemia Vera (22.03.2019 - 31.03.2024)
- Knapper, Steven
Phase 1b study of Venetociax and Alvocidib in patients with relapsed/refractory Acute Myeloid Leukaemia (22.03.2019 - 31.03.2022)
- Alvares, Caroline
Barriers to and facilitators of physical activity in cancer patients with brain tumours in Wales and Bangladesh (01.04.2019 - 31.12.2023)
- Islam, Ishrat
Development of Functional neuroimaging pathway for patients with suspected dementia in the ABUHB area enabling access to FDGPET and Amyloid PET scans were appropriate. (01.04.2019 - 31.03.2020)
- Marshall, Christopher
Investigating the interactions between TLRs/NLRs and complement (01.04.2019 - 31.12.2024)
- Triantafilou, Kathy
Investigation of the roles of KL in suppression of renal cancer in a mouse model (01.04.2019 - 31.03.2022)
- Tee, Andrew
Lifestyle targets for improving prognosis in Huntington's disease (DOMINO-HD) (01.04.2019 - 31.01.2024)
- Busse-Morris, Monica
Madeline dementia test-bed project (01.04.2019 - 30.04.2021)
- Weeks, Ian
Multi-Domain lifestyle targets for improving prognosis in Huntington's disease (DOMINO-HD) (01.04.2019 - 31.10.2023)
- Busse-Morris, Monica
Overexpression of capillary morphogenesis gene 2 (CMG2) enhances tumour cell-orientated tumour microenvironment during tumour genesis and metastasis of pancreatic cancer (01.04.2019 - 31.12.2020)
- Ye, Lin
Rapid detection of life threatening neurological infection by detecting immune fingerprints in cerebrospinal fluid (01.04.2019 - 31.03.2020)
- Eberl, Matthias
Research Assessment Outcome Measures for Malignant Bowel Obstruction (RAMBO) (01.04.2019 - 31.03.2022)
- Noble, Simon
STRETCHED: STRategies to manage Emergency ambulance Telephone Callers with sustained High needs- an Evaluation using linked Data (01.04.2019 - 30.09.2021)
- Edwards, Adrian
The developmental origins of health: Biology, shocks, investments, and policies (01.04.2019 - 31.03.2025)
- Robling, Michael
The development of a scalable sustainable researcher training programme to enhance compliant use of routine data in research (01.04.2019 - 31.10.2020)
- Robling, Michael
The role of antibody in enabling cell-mediated control of HCMV infection (01.04.2019 - 31.01.2024)
- Stanton, Richard
Understanding the modulation of the innate immune system by MCR-producing enterobacteriaceae during infection (01.04.2019 - 31.03.2020)
- Walsh, Timothy
Pattern of IL-6 inhibitor versus TNF inhibitors use in patients with Rheumatoid Arthritis in South Wales, a Real-Life Study (11.04.2019 - 31.12.2024)
- Choy, Ernest
Clinical research fellow in genomic medicine (29.04.2019 - 30.06.2024)
- Sampson, Julian
A randomized, double blind, active control study of the safety and efficacy of PRX102 compared to Agasidase Beta on renal function in patients with Fabry disease previously treated with Agalidase (30.04.2019 - 30.04.2022)
- Cole, Duncan
Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, smarter, faster (01.05.2019 - 30.04.2023)
- Dayan, Colin
Integrating genetic and functional data to identify pathogenic pathways modifying the progression and phenotypic expression of Huntington's disease (01.05.2019 - 31.10.2021)
- Holmans, Peter
Pathway to Portfolio (01.05.2019 - 31.10.2019)
- Dolwani, Sunil
Testing the improvement in brain penetrance therapeutic antibodies through coupling to a transporter peptide (01.05.2019 - 31.10.2019)
- Hughes, Timothy
The feasibility and acceptability of a planned pre-pregnancy weight loss intervention: The Plan-it study (01.05.2019 - 31.10.2021)
- Channon, Sue
Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting type 1 diabetes (01.05.2019 - 31.10.2023)
- Wilhelm-Benartzi, Charlotte
Trauma-AID; Eye movement desensitisation and reprocessing for symptoms of post-traumatic stress disorder in adults with intellectual disabilities (01.05.2019 - 30.04.2023)
- Bisson, Jonathan
UKT1D-RC - Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, smarter, faster (01.05.2019 - 30.11.2025)
- Dayan, Colin
Clinical trial fellow in association with The Centre for Trials Research (01.06.2019 - 30.04.2022)
- Adams, Richard
Identification of the molecular mechanisms underlying disease variation, severity and progression in Parkinson’s disease using cohorts of deeplyphenotyped patients and human induced pluripotent stem cell models (01.06.2019 - 31.03.2023)
- Sandor, Cynthia
Impact of a network multidisciplinary team approach on clinical outcomes and cost effectiveness in the management of significant colorectal polyps (01.06.2019 - 31.03.2021)
- Dolwani, Sunil
Impact of Brexit on the health and wellbeing of rural communities in Wales - piloting a co-produced evidence-based model of support (01.06.2019 - 31.10.2019)
- Townson, Julia
Optimisation of molecular testing in newly-diagnosed acute myeloid leukaemia (AML) in Wales (01.06.2019 - 31.12.2021)
- Knapper, Steven
Readiness of lung cancer screening services to deliver concurrent smoking cessation treatment: Guideline and implementation toolkit development (01.06.2019 - 30.06.2021)
- Mccutchan, Grace
Testing novel agents in myasthenia gravis models (01.06.2019 - 31.12.2020)
- Morgan, Paul
UK Consortium for MetAbolic Phenotyping (MAP UK) (01.06.2019 - 31.05.2024)
- O'Donnell, Valerie
Understanding the scale and nature of avoidable harm in prison healthcare (01.06.2019 - 30.11.2023)
- Edwards, Adrian
A phase 2, randomized, biomarker-driven, clinical study in patients with relapsed or refractory AML with an exploratory arm in patients with newly diagnosed high-risk AML and exploratory arms with varying levels of MCL-1 dependence (13.06.2019 - 30.06.2023)
- Knapper, Steven
HealthWise Wales postal recruitment trial by WIMD (14.06.2019 - 30.06.2020)
- Dolwani, Sunil
Consulting on clinical development plan and phase 3 designs in PNH along the crovalimab late development (15.06.2019 - 31.12.2021)
- Morgan, Paul
Mechano-transduction modelling of the bone niche driving prostate metastatic cancer (17.06.2019 - 30.09.2023)
- Errington, Rachel
A multicentre cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of an environmental nutrition and physical activity intervention in nurseries NAP SACC UK (01.07.2019 - 31.10.2024)
- White, James
A multicentre cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of KiVa to reduce bullying in primary schools: The UK KiVa Trial (01.07.2019 - 30.09.2023)
- Townson, Julia
A randomized multicentre, double-blind placebo-controlled phase III clinical study to evaluate the efficacy and safety of intrathecally administered R07234292 (RG6042) in patients with manifest Huntington's disease (01.07.2019 - 31.05.2022)
- Rosser, Anne
Back to basics: The role of complement C3 and it's degradation fragments in immune-inflammatory disease (01.07.2019 - 31.12.2022)
- Morgan, Paul
Decisive - DiagnosE using the Central vein SIgn. A prospective diagnostic superiority study comparing T2* MRI and lumbar puncture in patients with possible Multiple Sclerosis (01.07.2019 - 30.06.2022)
- Tallantyre, Emma
Does the gut microbiome influence risk of getting dementia? (01.07.2019 - 31.12.2021)
- Morgan, Paul
Exploring a genetically targeted therapeutic approach for adenomatous polyposis syndromes in 3D Organoid cell models (01.07.2019 - 01.05.2023)
- Sampson, Julian
Flexible Funding (01.07.2019 - 31.03.2023)
- Williams, Julie
ImmuScreen (01.07.2019 - 31.08.2022)
- Godkin, Andrew
Optimization of scanning with CZT gamma cameras to improve the detection of metastatic spread to the bone in a range of cancers (01.07.2019 - 30.06.2024)
- Marshall, Christopher
PAULA - Personal AUtomated Lab Assistant (01.07.2019 - 30.06.2020)
- Sampson, Julian
PhD Studentship - Amr Yousef A Maqnas (01.07.2019 - 30.06.2023)
- Wood, Fiona
Revealing how long-term survivors are immune to cancer (01.07.2019 - 30.06.2022)
- Sewell, Andrew
Use of technological platforms to enhance phenotypic understanding in primary dystonia (01.07.2019 - 01.05.2023)
- Peall, Kathryn
An Innovative model system of cell invasion in TSC/LAM to uncover new drug targets and therapies (15.07.2019 - 15.06.2022)
- Dunlop, Elaine
An innovative model system of cell invasion in TSL/LAM to uncover new drug targets and therapies (15.07.2019 - 14.06.2022)
- Dunlop, Elaine
LEAP-MS study Excess Treatment Cost (01.08.2019 - 31.10.2021)
- Busse-Morris, Monica
Research into methods of preventing burn injuries in the home grant: Safe tea - A multimedia campaign to prevent scalds to young children from hot drinks (01.08.2019 - 30.04.2020)
- Kemp, Alison
Use of technological platforms to enhance phenotypic understanding in primary dystonia (01.08.2019 - 31.07.2022)
- Peall, Kathryn
7/9 rare genetics disorders as a window into the genetic architecture of mental disorders (02.08.2019 - 31.03.2024)
- van den Bree, Marianne
Support for speciality registrars on the Public Health training programme (06.08.2019 - 31.07.2024)
- Hurt, Lisa
Moondance bowel cancer project (07.08.2019 - 06.10.2021)
- Dolwani, Sunil
The role of the HMGB1 alarmin in oligodenrogliogenesis and white matter repair (07.08.2019 - 28.02.2021)
- Ved, Ronak
To develop a radiolabelling strategy for Nottingham's nanoparticle using Cardiff's radiolabelling expertise (15.08.2019 - 15.10.2020)
- Paisey, Stephen
Investigating minimal residual disease maintenance by the tumour microenvironment in acute myeloid leukaemia (23.08.2019 - 14.10.2022)
- Alvares, Caroline
An integrated target validation and drug discovery platform for the identification of novel agents targeting genome stability for the treatment of cancer (01.09.2019 - 31.12.2021)
- Ottmann, Oliver